Literature DB >> 18452717

Carrageenan-induced NFkappaB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10.

Sumit Bhattacharyya1, Pradeep K Dudeja, Joanne K Tobacman.   

Abstract

Carrageenans are highly sulfated polysaccharides that are widely used as food additives due to their ability to improve food texture. They are also widely recognized for their ability to induce inflammation in animal models of colitis. Recently, we reported that carrageenan (CGN) activated a pathway of innate immunity in human colonic epithelial cells mediated by Bcl10 (B-cell CLL/lymphoma 10). However, increases in phospho-IkappaBalpha and Interleukin-8 (IL-8) were not completely inhibited by silencing Bcl10, suggesting that CGN also influenced another mechanism, or mechanisms, of inflammation. In this report, we demonstrate that CGN increases production of reactive oxygen species (ROS) in human colonic epithelial cells. The combination of ROS quenching by the free radical scavenger Tempol and of Bcl10 silencing by siRNA completely inhibited the CGN-induced increases in nuclear NFkappaB (p65), phospho-IkappaBalpha, and secretion of IL-8. The CGN-induced increase in ROS was associated with declines in phosphorylation of MAPK 12 (p38gamma), MAPK 13 (p38delta), and heat-shock protein (Hsp) 27. The CGN-induced decline in phospho-Hsp27 was reversed by co-administration of Tempol (100 nM), but unaffected by silencing Bcl10. Since Hsp27 phosphorylation is inversely associated with phosphorylation of the IkappaBalpha kinase (IKK) signalosome, CGN exposure appears to affect the IKK signalosome by both the catalytic component, mediated by ROS-phospho-Hsp27, and the regulatory component, mediated by Bcl10 interaction with IKKgamma (Nemo). Hence, the CGN-activated inflammatory cascades related to innate immunity and to generation of ROS may be integrated at the level of the IKK signalosome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452717      PMCID: PMC3698247          DOI: 10.1016/j.bbagen.2008.03.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  55 in total

1.  Functional responses of human neutrophils to sodium sulfite (Na2SO3) in vitro.

Authors:  P Labbé; M Pelletier; F O Omara; D Girard
Journal:  Hum Exp Toxicol       Date:  1998-11       Impact factor: 2.903

2.  NCM460, a normal human colon mucosal epithelial cell line.

Authors:  M P Moyer; L A Manzano; R L Merriman; J S Stauffer; L R Tanzer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

3.  The role of glutathione in chronic adaptation to oxidative stress: studies in a normal rat kidney epithelial (NRK52E) cell model of sustained upregulation of glutathione biosynthesis.

Authors:  J S Woods; T J Kavanagh; J Corral; A W Reese; D Diaz; M E Ellis
Journal:  Toxicol Appl Pharmacol       Date:  1999-11-01       Impact factor: 4.219

4.  Sulphur dioxide: a potent glutathione depleting agent.

Authors:  S C Langley-Evans; G J Phillips; A A Jackson
Journal:  Comp Biochem Physiol C Pharmacol Toxicol Endocrinol       Date:  1996-06

5.  Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal.

Authors:  N Osman; I F McKenzie; K Ostenried; Y A Ioannou; R J Desnick; M S Sandrin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

6.  Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production.

Authors:  Y Zhang; A Shaffer; J Portanova; K Seibert; P C Isakson
Journal:  J Pharmacol Exp Ther       Date:  1997-12       Impact factor: 4.030

7.  Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.

Authors:  T G Willis; D M Jadayel; M Q Du; H Peng; A R Perry; M Abdul-Rauf; H Price; L Karran; O Majekodunmi; I Wlodarska; L Pan; T Crook; R Hamoudi; P G Isaacson; M J Dyer
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

8.  Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).

Authors:  Q Zhang; R Siebert; M Yan; B Hinzmann; X Cui; L Xue; K M Rakestraw; C W Naeve; G Beckmann; D D Weisenburger; W G Sanger; H Nowotny; M Vesely; E Callet-Bauchu; G Salles; V M Dixit; A Rosenthal; B Schlegelberger; S W Morris
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

9.  Dephosphorylation of the small heat shock protein Hsp27 in vivo by protein phosphatase 2A.

Authors:  J Cairns; S Qin; R Philp; Y H Tan; G R Guy
Journal:  J Biol Chem       Date:  1994-03-25       Impact factor: 5.157

10.  ATP sulfurylases from sulfate-reducing bacteria of the genus Desulfovibrio. A novel metalloprotein containing cobalt and zinc.

Authors:  O Y Gavel; S A Bursakov; J J Calvete; G N George; J J Moura; I Moura
Journal:  Biochemistry       Date:  1998-11-17       Impact factor: 3.162

View more
  34 in total

1.  Hyperglycemia and advanced glycosylation end products suppress adipocyte apoE expression: implications for adipocyte triglyceride metabolism.

Authors:  Doris Joy Espiritu; Zhi Hua Huang; Yong Zhao; Theodore Mazzone
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-20       Impact factor: 4.310

2.  Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice.

Authors:  S Bhattacharyya; I O-Sullivan; S Katyal; T Unterman; J K Tobacman
Journal:  Diabetologia       Date:  2011-10-20       Impact factor: 10.122

3.  Carrageenan Inhibits Insulin Signaling through GRB10-mediated Decrease in Tyr(P)-IRS1 and through Inflammation-induced Increase in Ser(P)307-IRS1.

Authors:  Sumit Bhattacharyya; Leo Feferman; Joanne K Tobacman
Journal:  J Biol Chem       Date:  2015-03-17       Impact factor: 5.157

4.  Protective effect of gastrin-releasing peptide receptor antagonist in carrageenan-induced pleural inflammation in rats.

Authors:  Fabricia Petronilho; Bruna de Souza; Francieli Vuolo; César A F Benetton; Emilio L Streck; Rafael Roesler; Gilberto Schwartsmann; Felipe Dal-Pizzol
Journal:  Inflamm Res       Date:  2010-04-03       Impact factor: 4.575

5.  Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-κB activation following carrageenan.

Authors:  Sumit Bhattacharyya; Alip Borthakur; Arivarasu N Anbazhagan; Shivani Katyal; Pradeep K Dudeja; Joanne K Tobacman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-23       Impact factor: 4.052

6.  Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.

Authors:  Sumit Bhattacharyya; Leo Feferman; Joanne K Tobacman
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

7.  Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammation.

Authors:  Claudia Patrignani; David T Lafont; Valeria Muzio; Béatrice Gréco; Rob Hooft van Huijsduijnen; Paola F Zaratin
Journal:  J Inflamm (Lond)       Date:  2010-03-30       Impact factor: 4.981

8.  Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models.

Authors:  Kelen Freitas; Sudeshna Ghosh; F Ivy Carroll; Aron H Lichtman; M Imad Damaj
Journal:  Neuropharmacology       Date:  2012-10-16       Impact factor: 5.250

9.  ROS, Hsp27, and IKKbeta mediate dextran sodium sulfate (DSS) activation of IkappaBa, NFkappaB, and IL-8.

Authors:  Sumit Bhattacharyya; Pradeep K Dudeja; Joanne K Tobacman
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

10.  Degraded carrageenan causing colitis in rats induces TNF secretion and ICAM-1 upregulation in monocytes through NF-kappaB activation.

Authors:  Claudine Benard; Antonietta Cultrone; Catherine Michel; Carlos Rosales; Jean-Pierre Segain; Marc Lahaye; Jean-Paul Galmiche; Christine Cherbut; Hervé M Blottière
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.